![](/img/cover-not-exists.png)
A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen
Kimble, Thomas, Burke, Anne E., Barnhart, Kurt T., Archer, David F., Colli, Enrico, Westhoff, Carolyn L.Volume:
2
Year:
2020
Journal:
Contraception: X
DOI:
10.1016/j.conx.2020.100020
File:
PDF, 838 KB
2020